1. M R, M D, H T, K G, P M, M A. Evaluation of the Expression Level and Hormone Receptor Association of miR-126 in Breast Cancer. Indian J Clin Biochem [Internet]. 2019 Oct 1 [cited 2021 Sep 25];34(4):451–7. Available from: https://pubmed.ncbi.nlm.nih.gov/31686732/
2. Assad Samani L, Javadirad SM, Parsafar S, Tabatabaeian H, Ghaedi K, Azadeh M. TP53 rs1625895 is Related to Breast Cancer Incidence and Early Death in Iranian Population. Indian J Clin Biochem. 2019 Oct 1;34(4):485–9.
3. Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3’-untranslated region of ErbB4 in breast cancer. Mol Med Rep [Internet]. 2016 May 1 [cited 2021 Sep 25];13(5):4494–8. Available from: http://www.spandidos-publications.com/10.3892/mmr.2016.5078/abstract
4. Balmeh N, Tabatabaeian H, Asgari M, Mokhtarian R, Abharian PH, Azadeh M, et al. miR-195 down-regulation is a distinctive biomarker of HER2 positive state in breast cancer. Gene Reports. 2020 Sep 1;20:100703.
5. NR L, A R, R N, S A, SK S, SK H, et al. Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy. Crit Rev Oncol Hematol [Internet]. 2020 Jul 1 [cited 2021 Sep 25];151. Available from: https://pubmed.ncbi.nlm.nih.gov/32464482/
6. Fattahi Dolatabadi N, Dehghani A, Shahand E, Yazdanshenas M, Tabatabaeian H, Zamani A, et al. The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Hum Cell 2020 334 [Internet]. 2020 Sep 3 [cited 2021 Sep 25];33(4):1229–39. Available from: https://link.springer.com/article/10.1007/s13577-020-00422-x
7. D T, AS Y, D K, G B, GC K. Non-coding RNAs as potential therapeutic targets in breast cancer. Biochim Biophys acta Gene Regul Mech [Internet]. 2020 Apr 1 [cited 2021 Sep 25];1863(4). Available from: https://pubmed.ncbi.nlm.nih.gov/31048026/
8. Azadeh M, Salehzadeh A, Ghaedi K, Sasani ST. Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran). Gene Reports. 2021 Jun;23:101154.
9. Long Non-Coding RNAs and Breast Cancer.
10. ML P, J S-B, S M-P. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer. Cell Oncol (Dordr) [Internet]. 2019 Feb 15 [cited 2021 Sep 25];42(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30361825/
11. X Q, DH Z, N W, JH X, X W, W M. ceRNA in cancer: possible functions and clinical implications. J Med Genet [Internet]. 2015 Sep 10 [cited 2021 Sep 25];52(10):710–8. Available from: https://pubmed.ncbi.nlm.nih.gov/26358722/
12. Fan C-N, Ma L, Liu N. Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med 2018 161 [Internet]. 2018 Sep 27 [cited 2021 Sep 25];16(1):1–12. Available from: https://link.springer.com/articles/10.1186/s12967-018-1640-2
13. IS P, M T, Q T, T K, O T-U, JP G, et al. Differential effect of surgical manipulation on gene expression in normal breast tissue and breast tumor tissue. Mol Med [Internet]. 2018 Nov 16 [cited 2021 Sep 25];24(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30445902/
14. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res [Internet]. 2015 Apr 20 [cited 2021 Sep 25];43(7):e47–e47. Available from: https://academic.oup.com/nar/article/43/7/e47/2414268
15. S D, PS M. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics [Internet]. 2007 Jul 15 [cited 2021 Sep 25];23(14):1846–7. Available from: https://pubmed.ncbi.nlm.nih.gov/17496320/
16. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003 343 [Internet]. 2003 Jun 15 [cited 2021 Sep 25];34(3):267–73. Available from: https://www.nature.com/articles/ng1180
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci [Internet]. 2005 Oct 25 [cited 2021 Sep 25];102(43):15545–50. Available from: https://www.pnas.org/content/102/43/15545
18. Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A, Pierros V, et al. DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res [Internet]. 2020 Jan 8 [cited 2021 Aug 4];48(D1):D101–10. Available from: https://academic.oup.com/nar/article/48/D1/D101/5626521
19. Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A, Pierros V, et al. DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res [Internet]. 2020 Jan 8 [cited 2021 Sep 11];48(D1):D101–10. Available from: https://academic.oup.com/nar/article/48/D1/D101/5626521
20. H D, C S, P P, N G. miRWalk--database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform [Internet]. 2011 Oct [cited 2021 Jul 29];44(5):839–47. Available from: https://pubmed.ncbi.nlm.nih.gov/21605702/
21. H D, N G. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods [Internet]. 2015 Jul 30 [cited 2021 Jul 29];12(8):697. Available from: https://pubmed.ncbi.nlm.nih.gov/26226356/
22. EY C, CM T, Y K, Q D, Z W, GV M, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics [Internet]. 2013 Apr 15 [cited 2021 Sep 11];14. Available from: https://pubmed.ncbi.nlm.nih.gov/23586463/
23. MV K, MR J, AD R, NF F, Q D, Z W, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res [Internet]. 2016 Jul 8 [cited 2021 Sep 11];44(W1):W90–7. Available from: https://pubmed.ncbi.nlm.nih.gov/27141961/
24. Xie Z, Bailey A, Kuleshov M V., Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene Set Knowledge Discovery with Enrichr. Curr Protoc [Internet]. 2021 Mar 1 [cited 2021 Sep 11];1(3):e90. Available from: https://currentprotocols.onlinelibrary.wiley.com/doi/full/10.1002/cpz1.90
25. Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res [Internet]. 2021 Jan 8 [cited 2021 Jul 29];49(D1):D545–51. Available from: https://academic.oup.com/nar/article/49/D1/D545/5943834
26. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res [Internet]. 2000 Jan 1 [cited 2021 Jul 29];28(1):27–30. Available from: https://academic.oup.com/nar/article/28/1/27/2384332
27. A F, F K, G V, K S, P M-G, P P, et al. Reactome graph database: Efficient access to complex pathway data. PLoS Comput Biol [Internet]. 2018 Jan 1 [cited 2021 Jul 29];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/29377902/
28. B J, L M, G V, C G, P L, A F, et al. The reactome pathway knowledgebase. Nucleic Acids Res [Internet]. 2020 Jan 1 [cited 2021 Jul 29];48(D1):D498–503. Available from: https://pubmed.ncbi.nlm.nih.gov/31691815/
29. P S, A M, O O, NS B, JT W, D R, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res [Internet]. 2003 Nov [cited 2021 Sep 11];13(11):2498–504. Available from: https://pubmed.ncbi.nlm.nih.gov/14597658/
30. WW F, H H, R Z, C K, S W-S, Y D, et al. Transmembrane protein PERP is a component of tessellate junctions and of other junctional and non-junctional plasma membrane regions in diverse epithelial and epithelium-derived cells. Cell Tissue Res [Internet]. 2013 Jul [cited 2021 Sep 25];353(1):99–115. Available from: https://pubmed.ncbi.nlm.nih.gov/23689684/
31. M W, J L, Y Z, R H, X X, X G, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N 6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer [Internet]. 2020 Aug 25 [cited 2021 Sep 25];19(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32843065/
32. L X, X X, WL L, Y S, TJJ L, YJ L, et al. Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling. Oncogene [Internet]. 2018 Jan 18 [cited 2021 Sep 25];37(3):323–31. Available from: https://pubmed.ncbi.nlm.nih.gov/28925397/
33. K C, Z L, Z L, Y L, Q Z. PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF. Cancer Biol Ther [Internet]. 2011 Dec 15 [cited 2021 Sep 25];12(12):1114–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22236877/
34. T Z, D M, X J, Z W, Z C, Y L. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer. Endocrine [Internet]. 2019 Dec 1 [cited 2021 Sep 25];66(3):573–84. Available from: https://pubmed.ncbi.nlm.nih.gov/31332712/
35. B C, Z L, Y F, X W, Y X. Myocardin-related transcription factor A (MRTF-A) mediates doxorubicin-induced PERP transcription in colon cancer cells. Biochem Biophys Res Commun [Internet]. 2018 Sep 10 [cited 2021 Sep 25];503(3):1732–9. Available from: https://pubmed.ncbi.nlm.nih.gov/30078679/
36. F J, P W. Regulating DSC2 Expression Affects the Proliferation and Apoptosis of Prostate Cancer Cells. Cancer Manag Res [Internet]. 2020 [cited 2021 Sep 25];12:11453–62. Available from: https://pubmed.ncbi.nlm.nih.gov/33204158/
37. T C, Y C, L Y, T K, K Z, O H, et al. DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. Br J Cancer [Internet]. 2011 Mar 15 [cited 2021 Sep 25];104(6):1013–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21364582/
38. J P, Y C, C M, D W, J C, X M, et al. Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis. PLoS One [Internet]. 2014 Mar 24 [cited 2021 Sep 25];9(3). Available from: https://pubmed.ncbi.nlm.nih.gov/24664224/
39. MM O, CJ K, RJ W, DJ J, JL M-R, JA B, et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res [Internet]. 2005 Jun 16 [cited 2021 Sep 25];7(5). Available from: https://pubmed.ncbi.nlm.nih.gov/16168112/
40. S X, S H, D L, Q Z, Y Y, Z Y. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma. Anal Cell Pathol (Amst) [Internet]. 2020 [cited 2021 Sep 25];2020. Available from: https://pubmed.ncbi.nlm.nih.gov/32850288/
41. MP M, Ø F, H I, A S, L B, O B, et al. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. Br J Cancer [Internet]. 2012 Feb 14 [cited 2021 Sep 25];106(4):756–62. Available from: https://pubmed.ncbi.nlm.nih.gov/22333708/
42. Assad Samani L, Javadirad S-M, Parsafar S, Tabatabaeian H, Ghaedi K, Azadeh M. TP53 rs1625895 is Related to Breast Cancer Incidence and Early Death in Iranian Population. Indian J Clin Biochem 2018 344 [Internet]. 2018 Jun 21 [cited 2021 Sep 25];34(4):485–9. Available from: https://link.springer.com/article/10.1007/s12291-018-0774-6
43. NS C, C I, X L, J L, A M, AA P, et al. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. J Natl Cancer Inst [Internet]. 2020 [cited 2021 Sep 25];112(3):266–77. Available from: https://pubmed.ncbi.nlm.nih.gov/31124563/
44. WF W, N Z, YQ L, MY L, SQ X, W Y. LncRNA APPAT regulated miR-328a/Pkp1 signal pathway to participate in breast cancer. Eur Rev Med Pharmacol Sci [Internet]. 2020 [cited 2021 Sep 25];24(10):5493–503. Available from: https://pubmed.ncbi.nlm.nih.gov/32495884/
45. GG D, Y S, I Y. Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Med Oncol [Internet]. 2012 Sep [cited 2021 Sep 25];29(3):1518–22. Available from: https://pubmed.ncbi.nlm.nih.gov/21947748/
46. P L, S J, Y L, J Y, X G, SY C, et al. Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. EMBO J [Internet]. 2017 Jul 3 [cited 2021 Sep 25];36(13):1963–80. Available from: https://pubmed.ncbi.nlm.nih.gov/28507225/
47. L G, X L, Q G, X N, Y H, Q L, et al. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments. Cancer Cell Int [Internet]. 2020 Dec 1 [cited 2021 Sep 25];20(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33088217/
48. B W, W X, Y C, C G, G Z, C Y. CASC15: A Tumor-Associated Long Non-Coding RNA. Curr Pharm Des [Internet]. 2021 Sep 23 [cited 2021 Sep 25];27(1):127–34. Available from: https://pubmed.ncbi.nlm.nih.gov/32962611/
49. X G, Q C, Q Z, J W, H Z. The dual functions of the long noncoding RNA CASC15 in malignancy. Biomed Pharmacother [Internet]. 2021 Mar 1 [cited 2021 Sep 25];135. Available from: https://pubmed.ncbi.nlm.nih.gov/33433353/
50. P C, R C, H G, J C, R Z, B L, et al. CASC15 Polymorphisms are Correlated With Breast Cancer Susceptibility in Chinese Han Women. Clin Breast Cancer [Internet]. 2021 [cited 2021 Sep 25]; Available from: https://pubmed.ncbi.nlm.nih.gov/33551326/
51. R X, M Y, Y T, R D, D L. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer. Comput Math Methods Med [Internet]. 2021 [cited 2021 Sep 25];2021. Available from: https://pubmed.ncbi.nlm.nih.gov/33727952/
52. Y W, H Y, G Z, C L, S Z, R L, et al. hsa-miR-7-5p suppresses proliferation, migration and promotes apoptosis in hepatocellular carcinoma cell lines by inhibiting SPC24 expression. Biochem Biophys Res Commun [Internet]. 2021 Jul 5 [cited 2021 Sep 25];561:80–7. Available from: https://pubmed.ncbi.nlm.nih.gov/34020142/
53. C P, G S, M S, P W, Y G, Q N. Investigation of miR-93-5p and its effect on the radiosensitivity of breast cancer. Cell Cycle [Internet]. 2021 [cited 2021 Sep 25];20(12):1173–80. Available from: https://pubmed.ncbi.nlm.nih.gov/34024254/
54. Tavousi N, Taqizadeh Q, Fanavari Z, Nasiriyan E, Tabaeian P, Rezaei M, et al. ADAMTS5 modulates breast cancer development as a diagnostic biomarker and potential tumor suppressor, regulating by BAIAP2-AS1, VTI1B, CRNDE, and hsa-miR-135b-3p: integrated systems biology and experimental approach. 2022 Jul 27 [cited 2022 Aug 6]; Available from: https://www.researchsquare.com